| Initial public offering of up to [*] equity shares of face value of Rs. 1/- each ("Equity Shares") of Sahajanand Medical Technologies Limited (The "Company" or the "Issuer") for cash at a price of Rs. [*] per equity share including a share premium of Rs. [*] per equity share (The "Offer Price") aggregating up to Rs. 1500.00 crores (The "Offer"). The offer comprises of a fresh issue of up to [*] equity shares by the company aggregating up to Rs. 410.33 crores(The "Fresh Issue") and an offer for sale of upto [*] equity shares (The "Offered Shares") aggregating up to Rs. 1089.67 crores (The "Offer for Sale"), comprising of up to [*] equity shares aggregating to Rs. 100 crores by Dhirajkumar S.Vasoya, up to [*] equity shares aggregating up to Rs. 33.75 crores by Shree Hari Trust (acting through its trustee),up to [*] equity shares aggregating up to Rs. 635.56 crores by Samara Capital Markets Holding Limited and up to [*] equity shares aggregating up to Rs. 320.36 crores by Nhpea Sparkle Holding b.v.(collectively ,The "Selling Shareholders"),(The "Offer for sale,and together with the fresh issue,the "Offer"). The offer will constitute [*] % of the post-offer paid-up equity share capital of the company.
The company, in consultation with the brlms, is considering a pre-ipo placement of such number of equity shares for cash consideration aggregating up to Rs. 185 crres, at its discretion, ("pre-ipo placement"). the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the book running lead managers. if the pre-ipo placement is completed, the fresh issue size will be reduced to the extent of such pre-ipo placement, subject to compliance with the minimum offersize equirements prescribed under regulation 19(2)(b) of the scrr.
The face value of the equity share is Rs. 1 the offer price is [*] times the face value of the equity shares.
The price band and the minimum bid lot size will be decided by the company.
|